YFM Equity Partners

Type

Private equity

Status

Active

Location

Leeds, United Kingdom

Total investments

100

Average round size

4M

Portfolio companies

81

Rounds per year

2.38

Lead investments

49

Follow on index

0.19

Exits

13

Stages of investment
Private Equity
Areas of investment
BiotechnologySoftwareAnalyticsInformation TechnologyHealth CareHealth DiagnosticsSaaSManufacturingComputerTelecommunications

Summary

In 1982 was created YFM Equity Partners, which is appeared as VC. The company was established in Europe in United Kingdom. The main department of described VC is located in the London.

We also calculated 16 valuable employees in our database.

The top activity for fund was in 2012. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 deals per year. Opposing the other organizations, this YFM Equity Partners works on 11 percentage points less the average amount of lead investments. The real fund results show that this VC is 36 percentage points more often commits exit comparing to other companies. Deals in the range of 1 - 5 millions dollars are the general things for fund. The top amount of exits for fund were in 2009.

For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Matillion, Binx Health, B2M Solutions. Among the most popular fund investment industries, there are Telecommunications, Medical Device. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the YFM Equity Partners, startups are often financed by Oxford Capital Partners, Seraphim Capital, Nesta Ventures. The meaningful sponsors for the fund in investment in the same round are Nesta Ventures, Oxford Capital Partners, Seraphim Capital. In the next rounds fund is usually obtained by Oxford Capital Partners, Technology Venture Partners, Parkwalk Advisors.

Show more

Investor highlights

Stage focus
Seed
Geo focus
United Kingdom

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
100
Lead investments
49
Exits
13
Rounds per year
2.38
Follow on index
0.19
Investments by industry
  • Software (33)
  • Information Technology (23)
  • Biotechnology (15)
  • Telecommunications (14)
  • Health Care (10)
  • Show 131 more
Investments by region
  • United Kingdom (90)
  • United States (7)
  • Belgium (1)
Peak activity year
2012
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
15
Avg. valuation at time of investment
20M
Group Appearance index
0.43
Avg. company exit year
12
Avg. multiplicator
13.73
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Binx Health 28 Apr 2014 Biotechnology, Mobile, Health Care, Health Diagnostics, Medical Device Early Stage Venture 23M United States, Massachusetts, Boston
Fuuse 05 Jun 2024 Software, Electric Vehicle, Energy Management Early Stage Venture 11M Lancashire, Lancaster, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.